Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,259 signal articles · 39 in last 24h · 115,274 total before filter · latest 1h ago
39last 24h
1800last 7d
299● bullish (7d)
170● bearish (7d)
205publishers
AllMacro321Earnings849M&A104Regulatory25Product16Analyst25
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearishshow all (incl. clickbait)
Siemens Aktiengesellschaft Q3 Earnings Call Highlights
MarketBeat9d agobearish
Siemens Aktiengesellschaft Q3 Earnings Call Highlights

Siemens Aktiengesellschaft (ETR:SIE) reported record third-quarter results for fiscal 2026, supported by strong demand for data center infrastructure, industrial software and automation. The company raised its full-year earnings outlook after orders, revenue, industrial profit and free cash flow all

Nutrien (NTR) Q2 Earnings Miss Estimates
Zacks10d agobearish
Nutrien (NTR) Q2 Earnings Miss Estimates

Nutrien (NTR) delivered earnings and revenue surprises of -3.33% and +1.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Investing.com10d agobearish
Duolingo falls on weak revenue guidance despite Q2 beat

Investing.com -- Duolingo Inc (NASDAQ:DUOL) reported second quarter results that exceeded analyst expectations, but shares tumbled 11.6% in after-hours trading Wednesday following revenue guidance that fell short of Wall Street estimates.

Investing.com10d agobearish
AppLovin stock plunges 20% as top-line miss and soft guidance overshadow profit

Investing.com -- AppLovin Corporation (NASDAQ: APP) saw its shares crater 20% after delivering second-quarter results that proved sky-high profit growth isn’t always enough for Wall Street. Despite surging year-over-year earnings, the marketing software titan missed sales targets and issued a lukewarm forecast for the quarter ahead.

Bloomberg10d agobearish
CVS Falls After Preliminary 2027 Guidance Disappoints

(Bloomberg) -- CVS Health Corp. shares fell after the company gave preliminary 2027 profit guidance that disappointed investors and warned of challenges in its pharmacy benefit manager next year, overshadowing a better-than-expected second quarter report.Most Read from BloombergTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealSpaceX’s AI Splurge Puts Damper on Debut Earnings After IPOChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasi